Liabilities and Equity of TuHURA Biosciences, Inc./NV from 30 Jun 2011 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
TuHURA Biosciences, Inc./NV quarterly Liabilities and Equity in USD history and change rate from 30 Jun 2011 to 30 Sep 2025.
  • TuHURA Biosciences, Inc./NV Liabilities and Equity for the quarter ending 30 Sep 2025 was $25,697,048, a 521% increase year-over-year.
Source SEC data
View on sec.gov
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Change (%)

TuHURA Biosciences, Inc./NV Quarterly Liabilities and Equity (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $25,697,048 +$21,557,048 +521% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $34,621,304 +$28,419,304 +458% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $14,638,677 +$7,192,677 +97% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $19,966,684 +$15,604,893 +358% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 $4,140,000 +$2,663,000 +180% 30 Sep 2024 10-Q 14 Nov 2024 2025 Q1
Q2 2024 $6,202,000 +$2,223,000 +56% 30 Jun 2024 10-Q 14 Nov 2024 2025 Q1
Q1 2024 $7,446,000 +$706,000 +10% 31 Mar 2024 10-Q 14 May 2024 2024 Q3
Q4 2023 $4,361,791 -$5,555,209 -56% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $1,477,000 -$11,733,000 -89% 30 Sep 2023 10-Q 13 Nov 2023 2024 Q1
Q2 2023 $3,979,000 -$11,969,000 -75% 30 Jun 2023 10-K 07 Oct 2024 2024 FY
Q1 2023 $6,740,000 -$6,058,000 -47% 31 Mar 2023 10-Q 11 May 2023 2023 Q3
Q4 2022 $9,917,000 -$7,801,000 -44% 31 Dec 2022 10-Q 14 Feb 2023 2023 Q2
Q3 2022 $13,210,000 -$9,133,000 -41% 30 Sep 2022 10-Q 09 Nov 2022 2023 Q1
Q2 2022 $15,948,000 +$2,405,000 +18% 30 Jun 2022 10-K 18 Sep 2023 2023 FY
Q1 2022 $12,798,000 -$6,055,000 -32% 31 Mar 2022 10-Q 13 May 2022 2022 Q3
Q4 2021 $17,718,000 -$2,771,000 -14% 31 Dec 2021 10-Q 11 Feb 2022 2022 Q2
Q3 2021 $22,343,000 -$788,000 -3.4% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q1
Q2 2021 $13,543,000 +$10,605,000 +361% 30 Jun 2021 10-K 27 Sep 2022 2022 FY
Q1 2021 $18,853,000 +$13,750,759 +270% 31 Mar 2021 10-Q 13 May 2021 2021 Q3
Q4 2020 $20,489,000 +$13,980,933 +215% 31 Dec 2020 10-Q 12 Feb 2021 2021 Q2
Q3 2020 $23,131,000 +$14,767,243 +177% 30 Sep 2020 10-Q 12 Nov 2020 2021 Q1
Q2 2020 $2,938,000 -$1,099,255 -27% 30 Jun 2020 10-K 28 Sep 2021 2021 FY
Q1 2020 $5,102,241 +$2,645,115 +108% 31 Mar 2020 10-Q 13 May 2020 2020 Q3
Q4 2019 $6,508,067 +$2,470,515 +61% 31 Dec 2019 10-Q 13 Feb 2020 2020 Q2
Q3 2019 $8,363,757 +$3,613,884 +76% 30 Sep 2019 10-Q 13 Nov 2019 2020 Q1
Q2 2019 $4,037,255 -$3,037,600 -43% 30 Jun 2019 10-K 18 Sep 2020 2020 FY
Q1 2019 $2,457,126 -$7,219,712 -75% 31 Mar 2019 10-Q 14 May 2019 2019 Q3
Q4 2018 $4,037,552 -$8,178,564 -67% 31 Dec 2018 10-Q 11 Feb 2019 2019 Q2
Q3 2018 $4,749,873 -$9,698,290 -67% 30 Sep 2018 10-Q 13 Nov 2018 2019 Q1
Q2 2018 $7,074,855 -$836,166 -11% 30 Jun 2018 10-K 09 Sep 2019 2019 FY
Q1 2018 $9,676,838 +$7,335,947 +313% 31 Mar 2018 10-Q 15 May 2018 2018 Q3
Q4 2017 $12,216,116 +$8,621,660 +240% 31 Dec 2017 10-Q 14 Feb 2018 2018 Q2
Q3 2017 $14,448,163 +$9,401,276 +186% 30 Sep 2017 10-Q 09 Nov 2017 2018 Q1
Q2 2017 $7,911,021 +$1,555,222 +24% 30 Jun 2017 8-K 03 Jun 2019
Q1 2017 $2,340,891 +$1,185,580 +103% 31 Mar 2017 10-Q 12 May 2017 2017 Q3
Q4 2016 $3,594,456 +$1,409,863 +65% 31 Dec 2016 10-Q 10 Feb 2017 2017 Q2
Q3 2016 $5,046,887 +$2,015,426 +66% 30 Sep 2016 10-Q 10 Nov 2016 2017 Q1
Q2 2016 $6,355,799 +$3,780,378 +147% 30 Jun 2016 10-K 27 Sep 2017 2017 FY
Q1 2016 $1,155,311 -$2,257,970 -66% 31 Mar 2016 10-Q 12 May 2016 2016 Q3
Q4 2015 $2,184,593 -$1,943,785 -47% 31 Dec 2015 10-Q 12 Feb 2016 2016 Q2
Q3 2015 $3,031,461 -$1,465,871 -33% 30 Sep 2015 10-Q 16 Nov 2015 2016 Q1
Q2 2015 $2,575,421 -$2,428,489 -49% 30 Jun 2015 10-K 13 Sep 2016 2016 FY
Q1 2015 $3,413,281 -$340,872 -9.1% 31 Mar 2015 10-Q 15 May 2015 2015 Q3
Q4 2014 $4,128,378 -$190,370 -4.4% 31 Dec 2014 10-Q 12 Feb 2015 2015 Q2
Q3 2014 $4,497,332 -$895,704 -17% 30 Sep 2014 10-Q 07 Nov 2014 2015 Q1
Q2 2014 $5,003,910 -$1,517,238 -23% 30 Jun 2014 10-K 16 Nov 2015 2015 FY
Q1 2014 $3,754,153 -$3,939,106 -51% 31 Mar 2014 10-Q 15 May 2014 2014 Q1
Q4 2013 $4,318,748 +$4,135,918 +2262% 31 Dec 2013 10-K 28 Aug 2014 2014 FY
Q3 2013 $5,393,036 +$5,392,427 30 Sep 2013 10-Q 08 Nov 2013 2013 Q3
Q2 2013 $6,521,148 +$6,519,354 30 Jun 2013 10-Q 12 Aug 2013 2013 Q2
Q1 2013 $7,693,259 +$7,690,483 31 Mar 2013 10-Q 15 May 2013 2013 Q1
Q4 2012 $182,830 +$182,025 31 Dec 2012 10-K 28 Aug 2014 2014 FY
Q3 2012 $609* -$6,228 30 Sep 2012 10-Q/A 20 Dec 2012 2013 Q1
Q2 2012 $1,794* -$8,901 30 Jun 2012 10-Q 18 Jan 2013 2013 Q2
Q1 2012 $2,776* 31 Mar 2012 10-Q/A 05 Jun 2012 2012 Q3
Q4 2011 $805* 31 Dec 2011 10-Q 07 Feb 2012 2012 Q2
Q3 2011 $6,837* 30 Sep 2011 10-Q 10 Nov 2011 2012 Q1
Q2 2011 $10,695 30 Jun 2011 10-K/A 20 Dec 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.